CDX Regulatory News

PFAS: Maine's PFAS Exemption Deadline Has Passed

July 22, 2025

For manufacturers selling products in Maine, a critical regulatory deadline has now passed. June 1, 2025, was the final day for companies to apply for a "currently unavoidable use" (CUU) designation for products containing intentionally added per- and polyfluoroalkyl substances (PFAS).

This application was the only pathway to seek an exemption from the state's comprehensive ban on PFAS in products, which is set to take full effect on January 1, 2026.

To be granted a CUU exemption, manufacturers were required to provide robust evidence demonstrating that:

  • The use of PFAS is essential for the product to function as intended.
  • There are no safer or technically feasible alternatives available on the market.

Companies that missed the June 1 deadline or have their CUU applications denied will be legally required to cease selling any products containing intentionally added PFAS in Maine by the 2026 effective date. This underscores the state's firm commitment to phasing out these chemicals from consumer goods and requires immediate attention from any affected businesses to ensure compliance.
 

Identify PFAS risks in your supply chain

Thousands of PFAS substances face restrictions globally, and regulations change fast. CDX maps your product portfolio for PFAS exposure, analyzes concentration levels, and flags compliance gaps before they become costly problems.

Learn how CDX helps with PFAS compliance

Other News You May Be Interested In
 

EU proposes harmonised end-of-waste criteria for recycled plastic
August 10, 2026
EU proposes harmonised end-of-waste criteria for recycled plastic
Japan's PFHxS restriction enters into force, confirming import ban on treated products
August 10, 2026
Japan's PFHxS restriction enters into force, confirming import ban on treated products
UK explores its own Digital Product Passport record policy
August 10, 2026
UK explores its own Digital Product Passport (DPP) record policy, with call for evidence open until September

Stay informed. Get the latest regulatory updates, compliance insights, and CDX news delivered to your inbox.

Subscribe to our Newsletter